-
Bad news: Results of the first large-scale effectiveness trial for a microbicide indicate that while the candidate, Carraguard, is safe, it was not shown to be effective in preventing male-to-female transmission of HIV.
-
An experimental anti-HIV tenofovir gel is safe for women to use on a daily basis, according to research conducted by the scientists at the University of Pittsburgh (PA) School of Medicine and the University of Alabama at Birmingham (UAB).
-
Several strides have been made when it comes to cervical cancer prevention. Research has identified high-risk human papillomaviruses (HPVs) as causal agents, a test has been developed to detect HPV infection (Digene HPV Test, Digene Corp.; Gaithersburg, MD), and a vaccine (Gardasil, Merck & Co.; Whitehouse Station, NJ) is now marketed to prevent infection of the most common types of HPV.
-
In 1998, the United States was on the verge of eliminating syphilis, one of the most prevalent sexually transmitted diseases (STDs). Today, the national syphilis rate has increased for the seventh consecutive year, according to preliminary data presented at the March 2008 National STD Prevention Conference.
-
The Food and Drug Administration (FDA) has revised labeling on the contraceptive patch (Ortho Evra, Ortho-McNeil-Janssen Pharmaceuticals; Raritan, NJ) to include new epidemiology data on the risks of venous thromboembolism (VTE).
-
Data released at a recent international conference suggest that adult male circumcision, which has been seen as possibly reducing the risk of HIV transmission in Africa, could raise the risk for women there whose male partners seek the procedure after they are infected.
-
Good news for your patients who use oral contraceptives (OCs): A new analysis of 45 epidemiological studies shows that use of such pills during a woman's lifetime gives substantial long-term protection against ovarian cancer.
-
Results of a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) indicate that most of the 1,000 women polled often confused myth with fact when quizzed about cervical cancer prevention.
-
Patients seeking medication abortion using mifepristone (Mifeprex, Danco Group) may be asking questions after news agencies reported leukemia drug safety issues at a Chinese drug manufacturing firm that serves as the sole U.S. supplier of mifepristone.
-
A multidrug-resistant variant of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteria is emerging in cities on both coasts of the United States, according to data from a new California-led study.
